Form 4: Viatris Inc. Executive Rajiv Malik Reports Stock Transactions Following RSU Vesting

Rajiv Malik, President of Viatris Inc., reports the acquisition and disposal of common stock related to the vesting of performance and restricted stock units, along with associated tax withholdings.

Summary

• On March 2nd, 3rd, and 4th, 2024, Rajiv Malik, President of Viatris Inc., engaged in multiple transactions involving Viatris common stock.
• These transactions primarily involved the vesting of performance restricted stock units (PRSUs) and restricted stock units (RSUs) granted in previous years.
• The vesting of these units resulted in the acquisition of shares, followed by the disposal of shares to cover tax liabilities associated with the vesting.
• Specifically, shares were withheld to cover tax liabilities related to the vesting and settlement of PRSUs and RSUs granted on March 2, 2021, March 3, 2023, and March 4, 2022.
• Malik also acquired and disposed of dividend equivalent units (DEUs) associated with the RSUs.
• After these transactions, Malik directly owns 995,479 shares of Viatris common stock and indirectly owns 460,319 shares through an irrevocable trust.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock transactions by an executive, with no inherent positive or negative sentiment. It reflects standard compensation practices.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies, often tied to compensation packages that include stock options and restricted stock units. These transactions are closely monitored by investors as they can provide insights into an executive's perspective on the company's future performance. The vesting of RSUs and PRSUs is a standard part of executive compensation, designed to align the executive's interests with those of the shareholders.

Comparison to Industry Standards

• Executive compensation packages in the pharmaceutical industry often include a mix of salary, bonus, stock options, and restricted stock units.
• Companies like Pfizer, Merck, and Johnson & Johnson also utilize RSUs and PRSUs as part of their executive compensation plans.
• The vesting schedules and performance metrics associated with these units vary from company to company, but the general principle of aligning executive incentives with shareholder value remains consistent.
• Tax withholding practices related to RSU vesting are also standard across the industry, with companies typically withholding shares to cover the executive's tax liabilities.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they primarily reflect the execution of existing compensation agreements.
• Shareholders may view the transactions as a routine part of executive compensation and governance.

Key Dates